• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "Inhibition of p38 and ERK1/2 pathways by Sparstolonin B suppresses inflammation-induced melanoma metastasis" [Biomed. Pharmacother. 98 (2018) 382-389].

作者信息

Tang Ya-Min, Cao Qing-Yun, Guo Xing-Yu, Dong Shui-Hua, Duan Jin-Ao, Wu Qi-Nan, Liang Qiao-Li

机构信息

Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing, University of Chinese Medicine, Nanjing 210000, China.

Jiangsu Key Laboratory for Functional Substance of Chinese Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing, University of Chinese Medicine, Nanjing 210000, China.

出版信息

Biomed Pharmacother. 2023 Nov;167:115616. doi: 10.1016/j.biopha.2023.115616. Epub 2023 Oct 2.

DOI:10.1016/j.biopha.2023.115616
PMID:37793954
Abstract
摘要

相似文献

1
Corrigendum to "Inhibition of p38 and ERK1/2 pathways by Sparstolonin B suppresses inflammation-induced melanoma metastasis" [Biomed. Pharmacother. 98 (2018) 382-389].《斯巴司他宁B对p38和ERK1/2通路的抑制作用抑制炎症诱导的黑色素瘤转移》勘误[《生物医学与药物治疗》98 (2018) 382 - 389]
Biomed Pharmacother. 2023 Nov;167:115616. doi: 10.1016/j.biopha.2023.115616. Epub 2023 Oct 2.
2
Inhibition of p38 and ERK1/2 pathways by Sparstolonin B suppresses inflammation-induced melanoma metastasis.斯巴醇 B 通过抑制 p38 和 ERK1/2 通路抑制炎症诱导的黑色素瘤转移。
Biomed Pharmacother. 2018 Feb;98:382-389. doi: 10.1016/j.biopha.2017.12.047. Epub 2017 Dec 27.
3
Corrigendum to "Amiodarone induces cell proliferation and myofibroblast differentiation via ERK1/2 and p38 MAPK signaling in fibroblasts" [Biomed. Pharmacother. 115 (2019) 108889].《胺碘酮通过ERK1/2和p38 MAPK信号通路诱导成纤维细胞增殖和肌成纤维细胞分化》[《生物医学与药物治疗》115卷（2019年）108889页]的勘误
Biomed Pharmacother. 2019 Oct;118:109085. doi: 10.1016/j.biopha.2019.109085. Epub 2019 Jun 6.
4
'Corrigendum to "Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells" [Biomed. Pharmacother. 98 (2018) 36-44]'.
Biomed Pharmacother. 2022 Sep;153:113329. doi: 10.1016/j.biopha.2022.113329. Epub 2022 Jun 25.
5
Corrigendum to "Monastrol suppresses invasion and metastasis in human colorectal cancer cells by targeting fascin independent of kinesin-Eg5 pathway" [Biomed. Pharmacother. 175 (2024) 116785].《“Monastrol通过靶向肌动蛋白结合蛋白抑制人结肠癌细胞的侵袭和转移，与驱动蛋白-Eg5途径无关”的勘误》[生物医学与药物治疗175 (2024) 116785]
Biomed Pharmacother. 2024 Oct;179:117411. doi: 10.1016/j.biopha.2024.117411. Epub 2024 Sep 10.
6
Corrigendum to 'Metapristone suppresses non-small cell lung cancer proliferation and metastasis via modulating RAS/RAF/MEK/MAPK signaling pathway' [Biomed. Pharmacother. 90 (2017) 437-445].《米非司酮通过调节RAS/RAF/MEK/MAPK信号通路抑制非小细胞肺癌的增殖和转移》的勘误[《生物医学与药物治疗》90(2017)437 - 445]
Biomed Pharmacother. 2018 Feb;98:925-926. doi: 10.1016/j.biopha.2018.01.091.
7
Corrigendum to "MicroRNA-24-1 suppresses mouse hepatoma cell invasion and metastasis via directly targeting O-GlcNAc transferase" [Biomed. Pharmacother., vol. 91 (July 2017) Pages 731-738/BIOPHA 5337].《“MicroRNA-24-1通过直接靶向O-连接N-乙酰葡糖胺转移酶抑制小鼠肝癌细胞侵袭和转移”的勘误》[《生物医学与药物治疗》，第91卷（2017年7月），第731 - 738页/BIOPHA 5337]
Biomed Pharmacother. 2024 Aug;177:116946. doi: 10.1016/j.biopha.2024.116946. Epub 2024 Jun 19.
8
Corrigendum to "Apigenin Ameliorates Doxorubicin-induced Renal Injury via Inhibition of Oxidative Stress and Inflammation" [Biomed. Pharmacother. 137 (2021) 111308].《芹菜素通过抑制氧化应激和炎症改善阿霉素诱导的肾损伤》[《生物医学与药物治疗》137 (2021) 111308]的勘误
Biomed Pharmacother. 2024 Jul;176:116916. doi: 10.1016/j.biopha.2024.116916. Epub 2024 Jun 12.
9
Corrigendum to "Qiangguyin inhibited fat accumulation in OVX mice through the p38 MAPK signaling pathway to achieve anti-osteoporosis effects"[Biomed. Pharmacother. 158 (2023) 114122].《强骨饮通过p38丝裂原活化蛋白激酶信号通路抑制去卵巢小鼠脂肪堆积以实现抗骨质疏松作用》的勘误[《生物医学与药物治疗》158 (2023) 114122]
Biomed Pharmacother. 2024 Jul;176:116914. doi: 10.1016/j.biopha.2024.116914. Epub 2024 Jun 8.
10
Corrigendum to "ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes" [Biomed. Pharmacother. 126 (2020) 110066].《“ZSCAN16通过调节NF-kB、AKT、mTOR、P38等基因促进膀胱癌的增殖、迁移和侵袭”的勘误》[《生物医学与药物治疗》126卷（2020年）第110066页]
Biomed Pharmacother. 2020 Oct;130:110858. doi: 10.1016/j.biopha.2020.110858. Epub 2020 Oct 11.